COR
Cencora, Inc.
Cencora, Inc. (COR) has 4 SEC Form 4 filings (4 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 7, 2026.
Insiders have net bought $1.2M over the trailing 6 months. The largest single insider purchase in this window was $1.1M by Director DURCAN DERMOT MARK on Jun 18, 2026.
- Industry:Medical - Distribution
- CEO:Robert Mauch
- Employees:51,000
- HQ:Conshohocken, PA, US
- IPO:1995-04-04
Insider Buying
$1.2M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$59.9B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Tyler Lauren MFirst filing | Director | Purchase | 550 | $149K | Jun 24 | SEC ↗ |
DURCAN DERMOT MARKFirst filing | Director | Purchase | 4,000 | $1.1M | Jun 22 | SEC ↗ |
Congress trading COR
See timeline →- DRep. Jared MoskowitzSale$1,001 - $15,0002026-05-06
- DRep. Jared MoskowitzPurchase$1,001 - $15,0002026-03-23
- DRep. Jared MoskowitzPurchase$1,001 - $15,0002026-03-31
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Related companies
Cencora, Inc. is in the Wholesale Trade sector.